• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[前列腺癌的大规模筛查及年龄适宜性。群马泌尿肿瘤学研究组]

[The mass screening for prostate cancer and the age eligibility. Gunma Urological Oncology Study Group].

作者信息

Imai K, Suzuki T, Kumasaka H, Kurosawa I, Kurihara J, Machida M, Makino T, Kiren H, Sato J, Yamanaka H

出版信息

Nihon Hinyokika Gakkai Zasshi. 1996 Oct;87(10):1191-6. doi: 10.5980/jpnjurol1989.87.1191.

DOI:10.5980/jpnjurol1989.87.1191
PMID:8937115
Abstract

BACKGROUND

The age eligibility for the mass screening (MS) for prostate cancer was investigated.

METHODS AND MATERIALS

This study was performed in subjects examined by MS from 1981 to 1994 in Gunma Prefecture, Japan. MS was performed by digital rectal examination (DRE) and prostatic acid phosphatase from 1981 to 1991, and by DRE, transrectal ultrasonography and prostate specific antigen from 1992 to 1994.

RESULTS

It was demonstrated that the prostate cancer detection rate was affected by the ratio of subjects newly and previously examined, the age distribution in the group examined and the diagnostic modality. It was also demonstrated that the detection rate of early stage prostate cancer was also affected by the age distribution and the diagnostic modality. The effective detection rate was determined on the assumption that the purpose of MS is the detection of the subjects who have the indication for the radical prostatectomy, and the effective detection rate was calculated in the range from 50 to 69 years for age eligibility, and B and C for clinical stage. It was estimated that effective detection rate was 0.37 to 0.61%. They were higher than the detection rate of MS for other organ cancers.

CONCLUSION

The eligibility is 50 to 69 years. If subjects in the range of 70 to 74 are included in this project, it is necessary to make an effort practice a subject-education about the prostate cancer natural history and the radical prostatectomy indication.

摘要

背景

对前列腺癌群体筛查的年龄适宜性进行了调查。

方法与材料

本研究在1981年至1994年于日本群马县接受群体筛查的受试者中进行。1981年至1991年,群体筛查通过直肠指检(DRE)和前列腺酸性磷酸酶进行,1992年至1994年则通过DRE、经直肠超声检查和前列腺特异性抗原进行。

结果

结果表明,前列腺癌检出率受新检查和既往检查受试者的比例、受检群体的年龄分布以及诊断方式的影响。还表明,早期前列腺癌的检出率也受年龄分布和诊断方式的影响。假设群体筛查的目的是检测有前列腺癌根治术指征的受试者,据此确定有效检出率,并计算出年龄适宜范围为50至69岁、临床分期为B和C期时的有效检出率。估计有效检出率为0.37%至0.61%。这些比率高于其他器官癌症的群体筛查检出率。

结论

适宜年龄为50至69岁。如果将70至74岁的受试者纳入该项目,则有必要努力开展关于前列腺癌自然史和前列腺癌根治术指征的受试者教育。

相似文献

1
[The mass screening for prostate cancer and the age eligibility. Gunma Urological Oncology Study Group].[前列腺癌的大规模筛查及年龄适宜性。群马泌尿肿瘤学研究组]
Nihon Hinyokika Gakkai Zasshi. 1996 Oct;87(10):1191-6. doi: 10.5980/jpnjurol1989.87.1191.
2
Characteristics of prostate cancers detected in a multimodality early detection program. The Investigators of the American Cancer Society-National Prostate Cancer Detection Project.多模态早期检测项目中检测出的前列腺癌的特征。美国癌症协会-国家前列腺癌检测项目的研究人员。
Cancer. 1993 Sep 1;72(5):1701-8. doi: 10.1002/1097-0142(19930901)72:5<1701::aid-cncr2820720534>3.0.co;2-e.
3
[Screening examination for prostate cancer. Early detection and mass screening].
Nihon Hinyokika Gakkai Zasshi. 1993 Jul;84(7):1175-87. doi: 10.5980/jpnjurol1989.84.1175.
4
[Measurement of serum PSA by DELFIA PSA kit and its application for mass screening. The Gunma Urological Oncology Study Group].[使用DELFIA PSA试剂盒检测血清PSA及其在大规模筛查中的应用。群马泌尿肿瘤研究组]
Hinyokika Kiyo. 1993 Sep;39(9):807-12.
5
[Current status and problems of a screening for prostatic cancer in the health facilities in Fukuoka Prefecture].[福冈县医疗机构中前列腺癌筛查的现状与问题]
Nihon Hinyokika Gakkai Zasshi. 1993 Jul;84(7):1227-35. doi: 10.5980/jpnjurol1989.84.1227.
6
Evaluation of the digital rectal examination as a screening test for prostate cancer. Rotterdam section of the European Randomized Study of Screening for Prostate Cancer.直肠指检作为前列腺癌筛查试验的评估。欧洲前列腺癌筛查随机研究鹿特丹分部。
J Natl Cancer Inst. 1998 Dec 2;90(23):1817-23. doi: 10.1093/jnci/90.23.1817.
7
Free prostate-specific antigen improves prostate cancer detection in a high-risk population of men with a normal total PSA and digitalrectal examination.游离前列腺特异性抗原可改善总前列腺特异性抗原和直肠指检均正常的高危男性人群中前列腺癌的检测。
Urology. 2003 Apr;61(4):754-9. doi: 10.1016/s0090-4295(02)02524-4.
8
The value of screening tests in the detection of prostate cancer. Part II: Retrospective analysis of free/total prostate-specific analysis ratio, age-specific reference ranges, and PSA density.筛查试验在前列腺癌检测中的价值。第二部分:游离/总前列腺特异性抗原分析比值、年龄特异性参考范围及前列腺特异性抗原密度的回顾性分析
Urology. 1995 Dec;46(6):779-84. doi: 10.1016/S0090-4295(99)80343-4.
9
Clinical significance of prostate specific antigen for early stage prostate cancer detection.前列腺特异性抗原在早期前列腺癌检测中的临床意义。
Jpn J Clin Oncol. 1994 Jun;24(3):160-5.
10
[Prostatic specific antigen (PA) in mass screening for prostate cancer].[前列腺特异性抗原(PA)在前列腺癌大规模筛查中的应用]
Hinyokika Kiyo. 1992 Nov;38(11):1225-9.